CSF biomarkers of neuroinflammation are associated with regional atrophy
Authors:
Open Access
- 24 December 2025
- journal article
- research article
- Published by Springer Nature in Journal of Neurology
- Vol. 273 (1) , 46
Abstract
Background: Neuroinflammation is central to Alzheimer’s disease (AD) pathogenesis, yet its contribution to region‐specific brain atrophy remains unclear. We examined whether cerebrospinal fluid (CSF) biomarkers predict longitudinal atrophy in the hippocampus and basal forebrain and mediate the impact of AD pathology. Methods: Data from 227 DELCODE participants with baseline CSF measures and longitudinal structural MRI were analyzed. Four latent factors (synaptic, microglia, chemokine/cytokine, complement) were derived to capture shared variance across biomarkers. Latent factors represent unobserved biological domains inferred from related CSF markers. In addition, four single biomarkers (neurogranin, sTREM2, YKL-40, ferritin) were tested separately. Regional atrophy rates were estimated using linear mixed-effects models including biomarker × time, A/T classification, diagnosis, and covariates (age, sex, education, ApoE-ε4). Individual slopes were then entered into mediation models. Results: Higher synaptic latent factor ( β = − 0.019, pFDR = 0.021) and YKL-40 ( β = − 0.020, pFDR = 0.025) significantly predicted hippocampal atrophy. Only these two markers remained significant after correction for multiple comparisons. Mediation analyses revealed significant indirect effects of the synaptic latent factor and YKL-40 on hippocampal atrophy across all A/T groups. No biomarker was associated with basal forebrain atrophy (pFDR > 0.05). Conclusions: Latent factors captured shared biological variance across related biomarkers and provided a more robust representation of underlying biological domains than single biomarkers. This approach identified synaptic dysfunction and astroglial activation as key links between AD pathology and hippocampal neurodegeneration. These findings highlight synaptic and glial pathways as promising targets for disease-modifying interventions.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (374011584/3T)
- Deutsches Zentrum für Neurodegenerative Erkrankungen e.V. (DZNE) in der Helmholtz-Gemeinschaft
This publication has 71 references indexed in Scilit:
- Astrocyte in Neurological Disease: Pathogenesis and TherapyMedcomm, 2025
- The relationship between adult hippocampal neurogenesis and cognitive impairment in Alzheimer's diseaseAlzheimer's & Dementia, 2024
- Association between hippocampal microglia, AD and LATE‐NC, and cognitive decline in older adultsAlzheimer's & Dementia, 2024
- Association of latent factors of neuroinflammation with Alzheimer's disease pathology and longitudinal cognitive declineAlzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2024
- Association of CSF biomarkers with MRI brain changes in Alzheimer's diseaseAlzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2024
- Astrocyte biomarkers GFAP and YKL‐40 mediate early Alzheimer's disease progressionAlzheimer's & Dementia, 2023
- A study of the longitudinal changes in multiple cerebrospinal fluid and volumetric magnetic resonance imaging biomarkers on converter and non‐converter Alzheimer's disease subjects with consideration for their amyloid beta statusAlzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2022
- High complement levels in astrocyte‐derived exosomes of Alzheimer diseaseAnnals of Neurology, 2018
- Introduction to Confirmatory Factor Analysis and Structural Equation Modeling2013
- Microglial dystrophy in the aged and Alzheimer's disease brain is associated with ferritin immunoreactivityGlia, 2008